Stock·NYSE·Industrials
Equifax Inc. (EFX)
- Market cap
- $18.94B
- P/E
- 28.39
- Dividend yield
- 1.35%
- Street target
- $207.00median of 24 analysts
- 52-week range
- $137.01 $238.94
The short version
Where EFX stands today, in four lines, and what CleaRank Financial AI makes of it.
EFX at a glance
Equifax Inc. (EFX): Hold, 52/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($167.59 and $178.98).
- Earnings EFX beat estimates in 5 of its last 5 quarters, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $57.1M and bought $465K over the last 18 months.
- Valuation P/E of 28.4 against 34.0 for the Industrials sector: broadly in line with peers (-16%).
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates Equifax Inc. (EFX) Hold, with a model score of 52/100.
The analysts' outlook lifts the score most: 19 of 24 analysts rate it a buy and the median target is 28.4% above the price. The trend holds it back most: the price is 9.90% below its 200-day average and 3.78% below its 50-day average, and the 50-day average is 6.36% below the 200-day. The 50-day average stands at $167.59 and the 200-day at $178.98. Over the past year the price fell 29.03%.
Only on CleaRank
Figures we compute ourselves from EFX's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $161.25 is 3.8% below the 50-day simple moving average of $167.59.Price above its 200-day average ›
The price is 9.9% below the 200-day simple moving average of $178.98.50-day average above the 200-day ›
The 50-day average ($167.59) is 6.4% below the 200-day average ($178.98), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 24% of its 52-week range, between $137.01 and $238.94.
EFX share price
Pick a period: each tab shows how far EFX has moved over it, to the last close.
Today's trading
Where EFX sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 28.39 is 16.5% below the Industrials median of 34.0.P/S below the sector median ›
The price-to-sales ratio of 2.94 is 26.5% below the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was $691.4M on revenue of $6.4B, a net margin of 10.7%.Beat estimates in most recent reports ›
EFX beat the EPS estimate in 5 of its last 5 reports.Pays a dividend ›
The trailing dividend yield is 1.35%, or $2.18 a share a year.
Key statistics
The headline figures for EFX.
As of October 17, 2026, EFX trades at $161.25, with a market value of $18.94B, a P/E ratio of 28.39 and a dividend yield of 1.35%.
What the numbers say
CleaRank Financial AI's reading of EFX's valuation, growth and risks.
Equifax Inc. (EFX) has a trailing P/E of 28.39, set against an Industrials median of 34.0. That leaves it 16.5% below the sector median P/E, and the peer comparison on this page rates the multiple as broadly in line with peers. On sales, the P/S of 2.94 sits 26.5% below the sector median of 4.0. The company's market value stands at $18.9B.
Revenue grew 10.60% over the latest year, which is 1.1 percentage points behind the 11.7% median for Industrials. EFX turns sales into profit at a net margin of 10.73% and an operating margin of 17.31%, alongside a return on equity of 14.28%, below the sector median of 17.8%. It also reports debt-to-equity of 1.21 and a trailing dividend yield of 1.35% ($2.18 a share a year).
In its most recent report, on July 21, 2026, EFX posted EPS of $2.25 versus the $2.20 analysts expected, topping the estimate by 2.27%. The market reacted the other way, with the stock falling 1.47% the following session.
The record is a clean sweep: 5 beats in 5 reports, but beats have not guaranteed gains: the stock fell the next day after 1 of them. The consensus EPS estimate stands at $8.54 for this fiscal year and $10.06 for next, growth of 11.6% for the current year.
EFX typically moves about 2.25% in a day, which is the everyday swing investors should expect. The downtrend adds risk for as long as the price stays beneath both moving averages. The price is 32.51% below its 52-week high of $238.94. Insiders sold $57.1M of stock over the last 18 months and bought $465K. Insider sales are often planned in advance or made to cover tax on vesting shares, so they carry less weight than open-market buying.
EFX against the Industrials sector
How EFX compares with the median Industrials stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (-16% difference), suggesting fair market pricing relative to industry standards.
Return vs XLI: Since May 6, 2025, EFX has lost 38.5% against a gain of 25.7% for XLI.
Performance against XLI
EFX and the Industrials sector fund over the same days.
Revenue and earnings
How much EFX sells, and how much of it becomes profit.
Revenue growth: Revenue grew 6.9% in FY2025 to $6.1B, from $5.7B a year earlier.
Profit margin: The net margin was 10.9% in FY2025, up from 10.7% the year before.
Profitable: EFX earned $664M in FY2025.
Earnings reality check
Did EFX beat what analysts expected, and how did the stock react?
Earnings record: EFX beat the analyst estimate in 5 of the last 5 quarters.
Market reaction: The stock fell in the first session after 1 of those 5 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 21, 2026after close | $2.20 | $2.25 | +2.27% | -1.47% | +8.10% |
| Oct 21, 2025after close | $1.94 | $2.04 | +5.15% | +0.31% | -2.51% |
| Jul 22, 2025after close | $1.92 | $2.00 | +4.17% | +3.12% | +3.69% |
| Apr 22, 2025after close | $1.40 | $1.53 | +9.29% | +1.73% | +5.54% |
| Feb 6, 2025after close | $2.10 | $2.12 | +0.95% | +0.32% | +1.37% |
As of October 17, 2026, EFX has beaten the analyst EPS estimate in 5 of its last 5 reported quarters and fell in the first trading session after 1 of those beats; its latest report, on July 21, 2026, came in 2.27% above the estimate and the stock moved -1.47% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 59.3, in neutral territory.RSI above 50 ›
An RSI of 59.3 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of EFX
The score, the reasoning behind it, and what could move the price next.
Equifax Inc. (EFX) trades at $161.25, below both of its key moving averages. The price is 3.78% below its 50-day average of $167.59 and 9.90% below the 200-day average of $178.98. Sitting at 24% of its 52-week range, the stock is 17.69% above its 52-week low of $137.01. The 50-day average is 6.36% below the 200-day, which backs up the weak trend rather than pushing against it.
The price is down over each of these periods: 1.56% over the past month, 8.94% over the past three months and 29.03% over the past year. The price fell 0.01% in the last session on volume 31.8% above its average. On momentum, the 14-day RSI reads 59.3, in the neutral zone, with the MACD line negative.
Analyst upgrade ›
Rothschild & Co upgraded it to Buy from Neutral on August 21, 2026.
Source: Analyst action, Rothschild & Co, August 21, 2026Rating reaffirmed ›
Barclays kept its Equal-Weight rating on October 2, 2026.
Source: Analyst action, Barclays, October 2, 2026
Earnings beat ›
The July 21, 2026 report beat the EPS estimate by 2.27%, and the share price fell 1.47% in the first session after it.
Source: Earnings report, July 21, 2026
- Keep an eye on the two closest levels: the 50-day SMA at $167.59 sits above the price, and the 20-day EMA at $152.53 sits below it.
- The 14-day RSI reads 59.3, in the neutral zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
- Following the July 21, 2026 report, the share price dropped 1.47% in the first session, even though EFX has beaten estimates in 5 of the last 5 reports.
EFX remains in a downtrend while it trades below both its 50-day average of $167.59 and its 200-day average of $178.98. A close back above the 50-day average would be the first sign of a recovery. That same 50-day SMA at $167.59 is the first resistance level overhead.
To the downside, the first level below the price is the 20-day EMA at $152.53.
Technical indicators
Momentum and trend for EFX, from its daily closes.
As of October 17, 2026, with EFX at $161.25, its 14-day RSI is 59.3 (neutral territory), its 50-day simple moving average is $167.59 and its 200-day is $178.98.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What EFX moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, EFX's 1-year correlation of daily returns is +0.39 with S&P 500 (SPY), +0.26 with Nasdaq 100 (QQQ), +0.07 with Bitcoin (BTC) and +0.01 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
19 of 24 analysts rate it a buy or strong buy, 5 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $207.00 is 28.4% above the price.More buy ratings than three months ago ›
19 of 24 rate it a buy now, against 16 of 24 three months ago.
EFX Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 2, 2026 | Barclays | Maintains | Equal-Weight |
| Sep 30, 2026 | BMO Capital | Maintains | Market Perform |
| Sep 22, 2026 | Wells Fargo | Maintains | Overweight |
| Aug 21, 2026 | Rothschild & Co | Upgrade | Buy |
| Jul 22, 2026 | Wells Fargo | Maintains | Overweight |
| Jul 22, 2026 | Morgan Stanley | Maintains | Overweight |
As of October 17, 2026, 24 Wall Street analysts cover EFX: 19 rate it a buy or strong buy, 5 a hold and 0 a sell or strong sell. Their 12-month price targets range from $148.00 to $245.00, with a median of $207.00, 28.4% above the price of $161.25.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
EFX trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from EFX's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much EFX tends to move, against the market and on its own.
The long record
EFX's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move under 2% ›
The price has moved 2.25% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 53.2%, from August 2024 to September 2026; the price is still 46.5% below that peak.Most 1-year holds ended higher ›
58% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $13,689, against $42,055 in the S&P 500 (SPY).
EFX Drawdowns & Recovery
As of October 17, 2026, EFX's worst peak-to-trough fall over the last 10 years with dividends reinvested was -53.2% (August 2024 to September 2026); it is still 46.5% below that peak, and 58% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into EFX in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: EFX trailed the S&P 500 over this period: $13,689 against $42,055.
A $10,000 investment in EFX in October 2016 would be worth about $13,689 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to EFX, and which have not.
Strongest month, November: an average of +6.35%, up in 7 of 10 years.
Weakest month, September: an average of -8.12%, up in 1 of 10 years.
This month, October: has averaged -7.15%, up in 2 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, EFX's strongest calendar month has been November (average +6.35%, up in 7 of 10 years) and its weakest September (average -8.12%, up in 1 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in EFX, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in EFX today could grow to about $15,276 by 2036 in the base case, with a 90th-percentile outcome near $56,941 and a 10th-percentile outcome around $4,098. The simulation models price only; at today's 1.35% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
EFX Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $191 for EFX by 2030 in the base case, from $161 today (1.2x over 4 years). The 10th-percentile path ends near $83.12. These are outcomes of a Monte Carlo simulation run on EFX's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $111 | $168 | $255 | |
| 2028 | $97.45 | $176 | $316 | |
| 2029 | $89.07 | $183 | $376 | |
| 2030 | $83.12 | $191 | $439 | |
| 2031 | $78.61 | $199 | $505 |
Method: a lognormal simulation of EFX's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
EFX insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $465K on the open market and sold $57.1M.
As of October 17, 2026, EFX insiders reported 16 open-market sales worth $57.1M and 1 open-market purchase worth $465K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | John W Gamble Jr
Chief Operating Officer
|
Sell | 4.5K | $845.8K |
| Jul 24, 2026 | Mark W. Begor
Chief Executive Officer
|
Sell | 37.8K | $6.5M |
| Jul 24, 2026 | Mark W. Begor
Chief Executive Officer
|
Option | 37.8K | $4.2M |
| May 7, 2026 | Chad M Borton
Officer
|
Sell | 2.5K | $426.9K |
| May 7, 2026 | Mark L Feidler
Director
|
Grant | 1.3K | $220.1K |
| May 7, 2026 | Karen Linn Fichuk
Director
|
Grant | 1.3K | $220.1K |
| May 7, 2026 | G Thomas Hough
Director
|
Grant | 1.3K | $220.1K |
| May 7, 2026 | Barbara A Larson
Director
|
Grant | 1.3K | $220.1K |
| May 7, 2026 | Robert D Marcus
Director
|
Grant | 1.3K | $220.1K |
| May 7, 2026 | Scott A Mcgregor
Director
|
Grant | 1.3K | $220.1K |
| May 7, 2026 | John A Mckinley Jr
Director
|
Grant | 1.3K | $220.1K |
| May 7, 2026 | Melissa Dee Smith
Director
|
Grant | 1.3K | $220.1K |
| May 7, 2026 | Audrey Boone Tillman
Director
|
Grant | 1.3K | $220.1K |
| May 1, 2026 | John W Gamble Jr
Chief Operating Officer
|
Sell | 3.5K | $617.9K |
| Apr 24, 2026 | Mark W. Begor
Chief Executive Officer
|
Sell | 37.8K | $6.5M |
| Apr 24, 2026 | Mark W. Begor
Chief Executive Officer
|
Option | 37.8K | $4.2M |
| Mar 2, 2026 | David John Smith
Officer
|
Grant | 23.0K | - |
| Feb 25, 2026 | Mark W. Begor
Chief Executive Officer
|
Grant | 41.0K | - |
| Feb 25, 2026 | Sunil Bindal
Officer
|
Grant | 4.8K | - |
| Feb 25, 2026 | Chad M Borton
Officer
|
Grant | 16.5K | - |
| Feb 25, 2026 | Carla Chaney
Officer
|
Grant | 7.6K | - |
| Feb 25, 2026 | Jamil Farshchi
Chief Technology Officer
|
Grant | 14.2K | - |
| Feb 25, 2026 | John W Gamble Jr
Chief Operating Officer
|
Grant | 18.0K | - |
| Feb 25, 2026 | James M. Griggs
Officer
|
Grant | 1.6K | - |
| Feb 25, 2026 | Julia A Houston
Officer
|
Grant | 11.2K | - |
| Feb 25, 2026 | Cecilia H. Mao
Officer
|
Grant | 2.7K | - |
| Feb 25, 2026 | Patricio Remon
Officer
|
Grant | 5.4K | - |
| Feb 25, 2026 | Harald Schneider
Officer
|
Grant | 3.0K | - |
| Feb 25, 2026 | Kathryn Q Walker
Officer
|
Grant | 1.5K | - |
| Feb 23, 2026 | John W Gamble Jr
Chief Operating Officer
|
Sell | 4.5K | $880.7K |
| Feb 18, 2026 | Cecilia H. Mao
Officer
|
Buy | 2.4K | $464.9K |
| Feb 12, 2026 | Chad M Borton
Officer
|
Sell | 2.5K | $485.5K |
| Feb 11, 2026 | Jamil Farshchi
Chief Technology Officer
|
Sell | 7.4K | $1.4M |
| Feb 10, 2026 | Mark W. Begor
Chief Executive Officer
|
Sell | 37.8K | $7.6M |
| Feb 10, 2026 | Mark W. Begor
Chief Executive Officer
|
Grant | 33.3K | - |
| Feb 10, 2026 | Mark W. Begor
Chief Executive Officer
|
Option | 37.8K | $4.2M |
| Feb 10, 2026 | Sunil Bindal
Officer
|
Grant | 2.7K | - |
| Feb 10, 2026 | Carla Chaney
Officer
|
Grant | 4.4K | - |
| Feb 10, 2026 | Jamil Farshchi
Chief Technology Officer
|
Option | 6.2K | $1.2M |
| Feb 10, 2026 | Jamil Farshchi
Chief Technology Officer
|
Grant | 4.7K | - |
| Feb 10, 2026 | John W Gamble Jr
Chief Operating Officer
|
Grant | 11.0K | - |
| Feb 10, 2026 | Julia A Houston
Officer
|
Grant | 4.1K | - |
| Feb 10, 2026 | Cecilia H. Mao
Officer
|
Grant | 1.4K | - |
| Feb 10, 2026 | Harald Schneider
Officer
|
Grant | 1.4K | - |
| Feb 3, 2026 | Mark W. Begor
Chief Executive Officer
|
Grant | 59.1K | - |
| Nov 20, 2025 | John W Gamble Jr
Chief Operating Officer
|
Sell | 2.5K | $520.9K |
| Oct 27, 2025 | Mark W. Begor
Chief Executive Officer
|
Sell | 49.3K | $11.4M |
| Oct 27, 2025 | Jamil Farshchi
Chief Technology Officer
|
Sell | 4.9K | $1.2M |
| Oct 27, 2025 | Mark W. Begor
Chief Executive Officer
|
Option | 28.0K | $5.4M |
| Oct 27, 2025 | Mark W. Begor
Chief Executive Officer
|
Grant | 47 | - |
| Oct 27, 2025 | Jamil Farshchi
Chief Technology Officer
|
Option | 4.9K | $864.2K |
| Aug 18, 2025 | John W Gamble Jr
Chief Operating Officer
|
Sell | 3.0K | $742.1K |
| Jul 28, 2025 | Mark W. Begor
Chief Executive Officer
|
Sell | 48.3K | $11.7M |
| Jul 28, 2025 | Mark W. Begor
Chief Executive Officer
|
Option | 28.0K | $5.4M |
| May 30, 2025 | Harald Schneider
Officer
|
Grant | 957 | - |
| May 8, 2025 | Mark L Feidler
Director
|
Grant | 812 | - |
| May 8, 2025 | Karen Linn Fichuk
Director
|
Grant | 812 | - |
| May 8, 2025 | G Thomas Hough
Director
|
Grant | 812 | - |
| May 8, 2025 | Barbara A Larson
Director
|
Grant | 812 | - |
| May 8, 2025 | Robert D Marcus
Director
|
Grant | 812 | - |
| May 8, 2025 | Scott A Mcgregor
Director
|
Grant | 812 | - |
| May 8, 2025 | John A Mckinley Jr
Director
|
Grant | 812 | - |
| May 8, 2025 | Melissa Dee Smith
Director
|
Grant | 812 | - |
| May 8, 2025 | Audrey Boone Tillman
Director
|
Grant | 812 | - |
| May 6, 2025 | John W Gamble Jr
Chief Operating Officer
|
Sell | 2.0K | $518.2K |
| May 1, 2025 | Julia A Houston
Officer
|
Grant | 720 | - |
| Apr 28, 2025 | Mark W. Begor
Chief Executive Officer
|
Sell | 22.2K | $5.7M |
| Apr 28, 2025 | Mark W. Begor
Chief Executive Officer
|
Option | 22.2K | $3.9M |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.